Nuvo Group—a private company commercializing INVU™, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform, announced today that Stephen K. Klasko, MD MBA, President of Thomas Jefferson University and Chief Executive Officer of Jefferson Health, has been elected to the Company’s Board of Directors, effective August 31, 2020.
September 1, 2020
· 3 min read